Takuya Kuno

415 total citations
10 papers, 346 citations indexed

About

Takuya Kuno is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Takuya Kuno has authored 10 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in Takuya Kuno's work include Gut microbiota and health (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). Takuya Kuno is often cited by papers focused on Gut microbiota and health (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). Takuya Kuno collaborates with scholars based in Japan. Takuya Kuno's co-authors include Sumio Ohtsuki, Mio Hirayama‐Kurogi, Shingo Ito, Shingo Ito, Wataru Obuchi, Kenji Nakamura, Tetsuya Terasaki, Toshihiro Yoneyama, Hiroto Enari and Tsuyoshi Tomimori and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Ecological Indicators.

In The Last Decade

Takuya Kuno

10 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takuya Kuno Japan 8 162 97 77 54 44 10 346
Debra Luffer‐Atlas United States 14 176 1.1× 86 0.9× 150 1.9× 23 0.4× 29 0.7× 23 490
Sunny Lihua Cheng United States 7 205 1.3× 42 0.4× 45 0.6× 23 0.4× 67 1.5× 7 313
Jessica Bo Li Lu United States 12 100 0.6× 53 0.5× 97 1.3× 48 0.9× 13 0.3× 30 321
Margarita G. Ladona Spain 13 164 1.0× 75 0.8× 192 2.5× 44 0.8× 31 0.7× 20 524
Takushi Kanazu Japan 11 66 0.4× 97 1.0× 99 1.3× 59 1.1× 24 0.5× 26 317
Midori Ono Japan 15 202 1.2× 95 1.0× 49 0.6× 29 0.5× 38 0.9× 36 632
Stephan Schaller Germany 9 124 0.8× 46 0.5× 76 1.0× 36 0.7× 22 0.5× 29 376
Yukinaga Kishikawa Japan 11 113 0.7× 151 1.6× 185 2.4× 50 0.9× 49 1.1× 23 425
Cornelia M. Smith United States 6 110 0.7× 126 1.3× 258 3.4× 61 1.1× 10 0.2× 7 574
Tobias Klaassen Germany 8 64 0.4× 56 0.6× 101 1.3× 53 1.0× 13 0.3× 10 400

Countries citing papers authored by Takuya Kuno

Since Specialization
Citations

This map shows the geographic impact of Takuya Kuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuya Kuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuya Kuno more than expected).

Fields of papers citing papers by Takuya Kuno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuya Kuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuya Kuno. The network helps show where Takuya Kuno may publish in the future.

Co-authorship network of co-authors of Takuya Kuno

This figure shows the co-authorship network connecting the top 25 collaborators of Takuya Kuno. A scholar is included among the top collaborators of Takuya Kuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuya Kuno. Takuya Kuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kuno, Takuya, Liang Chen, Hisashi Miyamoto, et al.. (2021). In Vitro and In Vivo Antibacterial Activities of a Novel Quinolone Compound, OPS-2071, against Clostridioides difficile. Antimicrobial Agents and Chemotherapy. 65(4). 8 indexed citations
2.
Ohtsuki, Sumio & Takuya Kuno. (2020). S4.1 - Impact of intestinal flora on host metabolism of drug, sugar and lipid. Drug Metabolism and Pharmacokinetics. 35(1). S9–S9. 1 indexed citations
3.
Kuno, Takuya, Mio Hirayama‐Kurogi, Shingo Ito, & Sumio Ohtsuki. (2019). Proteomic analysis of small intestinal epithelial cells in antibiotic-treated mice: Changes in drug transporters and metabolizing enzymes. Drug Metabolism and Pharmacokinetics. 34(2). 159–162. 9 indexed citations
4.
Kuno, Takuya, Mio Hirayama‐Kurogi, Shingo Ito, & Sumio Ohtsuki. (2018). Reduction in hepatic secondary bile acids caused by short-term antibiotic-induced dysbiosis decreases mouse serum glucose and triglyceride levels. Scientific Reports. 8(1). 1253–1253. 84 indexed citations
5.
Kuno, Takuya, Shingo Ito, & Sumio Ohtsuki. (2018). Effect of changes in intestinal flora induced by short-term antibiotics administration on the pharmacokinetics of drugs, and glucose and lipid metabolism. Drug Metabolism and Pharmacokinetics. 33(1). S56–S56. 3 indexed citations
6.
Enari, Hiroto, et al.. (2017). Feasibility assessment of active and passive acoustic monitoring of sika deer populations. Ecological Indicators. 79. 155–162. 28 indexed citations
8.
Kuno, Takuya, Mio Hirayama‐Kurogi, Shingo Ito, & Sumio Ohtsuki. (2016). Effect of Intestinal Flora on Protein Expression of Drug-Metabolizing Enzymes and Transporters in the Liver and Kidney of Germ-Free and Antibiotics-Treated Mice. Molecular Pharmaceutics. 13(8). 2691–2701. 80 indexed citations
9.
Mizutani, Takaharu, et al.. (2005). Autoantibodies Against CYP2D6 and Other Drug-Metabolizing Enzymes in Autoimmune Hepatitis Type 2. Drug Metabolism Reviews. 37(1). 235–252. 14 indexed citations
10.
Miyaichi, Yukinori, et al.. (1999). Studies on the Constituents of Scutellaria Species XX : Constituents of Roots of Scutellaria strigillosa HEMSL.. Natural medicines = 生薬學雜誌. 53(5). 237–241. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026